DrugPatentWatch Database Preview

Litigation Details for Osmotica Pharmaceutical US LLC v. Adamas Pharmaceuticals, Inc. (D. Del. 2018)

Docket	Start Trial	Date Filed	2018-02-16
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Gregory Moneta Sleet
Jury Demand	Plaintiff	Referred To
Parties	ADAMAS PHARMA, LLC; ADAMAS PHARMACEUTICALS, INC.; OSMOTICA PHARMACEUTICAL US LLC; VERTICAL PHARMACEUTICALS, LLC
Patents	8,389,578; 8,741,343; 8,796,337; 8,889,740; 8,895,614; 8,895,615; 8,895,616; 8,895,617; 8,895,618; 9,867,791; 9,867,792; 9,867,793
Attorneys	Adam LaRock; Adam Wyatt Poff; Alison Mulry; Bruce M. Wexler; Charles T. Wysocki; Dennies Varughese; Isaac S. Ashkenazi; Jack B. Blumenfeld; Jeremy A. Tigan; Matthew M. Zuziak; Pilar Gabrielle Kraman; Scott F. Peachman
Firms	Morris, Nichols, Arsht & Tunnell; Young, Conaway, Stargatt & Taylor LLP
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is Start Trial .

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00	1		claim of U.S. Patent Nos. 8,389,578 (“the ’578 patent”); 8,741,343 (“the ’343 patent”); 8,796,337 (“…now U.S. Patent No. 8,389,578. The ’578 patent claims the benefit to U.S. Provisional Patent Application…now U.S. Patent No. 8,389,578. The ’578 patent claims the benefit to U.S. Provisional Patent Application… now U.S. Patent No. 8,389,578. The ’578 patent claims benefit to U.S. Provisional Patent Application… now U.S. Patent No. 8,389,578. The ’578 patent claims benefit to U.S. Provisional Patent Application	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document